Biogen (BIIB) Assets (2009 - 2026)
Biogen's Assets was $32.09 billion in Q2 2026, up 13.3% from $28.33 billion a year earlier and up 8.8% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Assets at Biogen came in at $29.44 billion, up 5.0% from FY2024.
- Assets has now increased for four consecutive years, with a five-year compound annual growth rate of 3.6% (FY2020 to FY2025).
- In earlier years, Assets was $28.05 billion in FY2024 (+4.5%), $26.84 billion in FY2023 (+9.3%), $24.55 billion in FY2022 (+2.8%) and $23.88 billion in FY2021 (-3.0%).
- The Q2 2026 figure marks the highest quarterly Assets in data going back to Q2 2009.
- Compared with a year earlier, Assets has increased for 17 straight quarters, with growth averaging 5.3% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q3 2023 (growth of 13.4%); the worst was Q3 2021 (a decline of 4.5%).
- Per Business Quant data, BIIB's Assets in the three quarters before Q2 2026 was $29.48 billion (Q1 2026), $29.44 billion (Q4 2025) and $29.21 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn | 32.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.09 Bn |
| Mar 31, 2026 | 29.48 Bn |
| Dec 31, 2025 | 29.44 Bn |
| Sep 30, 2025 | 29.21 Bn |
| Jun 30, 2025 | 28.33 Bn |
| Mar 31, 2025 | 28.03 Bn |
| Dec 31, 2024 | 28.05 Bn |
| Sep 30, 2024 | 28.31 Bn |
| Jun 30, 2024 | 26.80 Bn |
| Mar 31, 2024 | 26.57 Bn |
| Dec 31, 2023 | 26.84 Bn |
| Sep 30, 2023 | 28.19 Bn |
| Jun 30, 2023 | 25.16 Bn |
| Mar 31, 2023 | 24.60 Bn |
| Dec 31, 2022 | 24.55 Bn |
| Sep 30, 2022 | 24.85 Bn |
| Jun 30, 2022 | 25.08 Bn |
| Mar 31, 2022 | 23.61 Bn |
| Dec 31, 2021 | 23.88 Bn |
| Sep 30, 2021 | 23.81 Bn |
API Access
Biogen Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();